Relievant Medsystems
-
Financial
Boston Scientific Closes Acquisition of Relievant Medsystems, Inc.
Recent healthcare plan coverage of Intracept® system expands access to vertebrogenic pain treatment for tens of millions of patients MARLBOROUGH, Mass., Nov. 17,…
Read More » -
Spine
Relievant Medsystems Announces Positive Coverage Policy for the Intracept Procedure from Anthem Blue Cross and Blue Shield
Expands access to vertebrogenic pain treatment for 36 million patients MINNEAPOLIS, Oct. 03, 2023 (GLOBE NEWSWIRE) — Relievant Medsystems, a company…
Read More » -
Financial
Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
Acquisition intended to expand neuromodulation portfolio to provide more treatment options for people living with chronic low back pain MARLBOROUGH,…
Read More » -
Neuro
Relievant Medsystems Announces Pooled 4-Year Outcomes Validating Long-Term Effectiveness of the Intracept Procedure
Findings, Presented at Annual American Society of Pain & Neuroscience Conference, Demonstrate Significant and Durable Relief of Chronic Vertebrogenic Low…
Read More » -
Spine
Relievant Medsystems Introduces Next-Generation Access Instruments to Advance Intracept Procedure for Chronic Vertebrogenic Low Back Pain
MIAMI, July 14, 2023 (GLOBE NEWSWIRE) — ASPN Annual Conference – Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of…
Read More » -
Financial
Relievant Medsystems Announces Favorable Coverage Policy from Cigna Healthcare for the Intracept Procedure
MINNEAPOLIS, June 20, 2023 (GLOBE NEWSWIRE) — Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic low…
Read More » -
Spine
Relievant Medsystems Announces Pooled Three-Year Outcomes from Intracept Procedure that Demonstrate Long-Term Pain Relief and Reduced Opioid Use in Chronic Vertebrogenic Low Back Pain Patients
MINNEAPOLIS, June 15, 2023 (GLOBE NEWSWIRE) — Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic low…
Read More » -
Financial
Relievant Medsystems Raises $50 Million to Advance the Treatment for Chronic Vertebrogenic Low Back Pain
MINNEAPOLIS, April 20, 2023 (GLOBE NEWSWIRE) — Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic…
Read More » -
Spine
Relievant Medsystems Announces Updated Policy Statement and Guideline for Basivertebral Nerve Ablation from the International Society for the Advancement of Spine Surgery
MINNEAPOLIS, Nov. 09, 2022 (GLOBE NEWSWIRE) — Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain,…
Read More » -
Spine
Relievant Medsystems Announces New Category I CPT Codes for Intracept® Procedure
MINNEAPOLIS, Jan. 03, 2022 (GLOBE NEWSWIRE) — Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic…
Read More » -
Spine
Relievant Announces Publication of 5-Year Data Demonstrating Long Term Clinical Benefits of the Intracept Procedure in Chronic Low Back Pain Patients
MINNEAPOLIS, June 08, 2020 (GLOBE NEWSWIRE) — Relievant Medsystems, a privately-held medical device company transforming the treatment of Chronic Low…
Read More » -
Spine
Relievant Announces Publication of Positive Results from Multi-Center Study of the Intracept® Procedure in Real-world Setting for Patients with Chronic Low Back Pain
MINNEAPOLIS, Aug. 27, 2019 (GLOBE NEWSWIRE) — Relievant Medsystems, a privately-held medical device company transforming the treatment of Chronic Low…
Read More » -
Spine
Relievant Announces Publication of SMART Trial 24-Month Results
MINNEAPOLIS, April 24, 2019 (GLOBE NEWSWIRE) — Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low…
Read More » -
Financial
Relievant Announces Reimbursement Codes and APC Assignment for The Intracept® Procedure
MINNEAPOLIS, Jan. 08, 2019 (GLOBE NEWSWIRE) — Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low…
Read More » -
Spine
Phoenix Spine Announces Participation in the INTRACEPT Study for the Treatment of Chronic Low Back Pain
SCOTTSDALE, Ariz., March 8, 2018 /PRNewswire/ — Phoenix Spine today announced participation in a clinical study comparing the Intracept Procedure, developed by Relievant…
Read More »